Executives at more than a dozen generic-drug companies had a form of shorthand to describe how they conducted business, insider lingo worked out over steak
Officials with Gilead Sciences, Inc. plan to launch authorized generic versions of sofosbuvir 400 mg/velpatasvir 100 mg (Epclusa) and ledipasvir 90mg/sofosbuvir 400 mg (Harvoni), Gilead’s leading
Sometimes IV bags are hard for hospitals to come by. Other times it’s injectable folic acid to treat anemias. Right now, the tissue-numbing agent lidocaine is in
To help speed up development and review of generic drugs, the FDA has released 2 new documents aimed at streamlining and improving aspects of the
Congress hasn’t made any progress on drug pricing legislation, but that hasn’t stopped the government from acting. Now, FDA Commissioner Scott Gottlieb has unveiled yet
